A new report highlights that all links in the hospital reporting chain are tragically weak.
Saskia v. Popescu
Advertisement
Saskia v. Popescu, PhD, MPH, MA, CIC, is a hospital epidemiologist and infection preventionist. During her work as an infection preventionist, she performed surveillance for infectious diseases, preparedness, and Ebola-response practices. She holds a doctorate in Biodefense from George Mason University where her research focuses on the role of infection prevention in facilitating global health security efforts. She is certified in Infection Control and has worked in both pediatric and adult acute care facilities.
Articles by Saskia v. Popescu
Are contaminated CRISPR kits a new source for resistant organisms?
Despite the best intentions, hospital accreditation surveys have become a breeding ground for low expectations.
Here’s how we are missing the bigger picture in the Sage chlorhexidine wipes debacle.
We are adding 2 more reasons to the 7 reasons we are more at risk than ever for a global pandemic.
Are efforts to back infection prevention studies biasing long-term efforts?
Just when you thought it was safe to go back into the endoscopy suite...
Sometimes the best surveillance tools are found in the gutter, at least according to a new study.
Our outlook on infectious diseases as threat to safety is outdated, but how do we change it?
As emerging infectious diseases and resistant bugs become a growing issue, the need for stronger disinfectants becomes even more vital.
The past few weeks have been busy with avian influenza activity from Tennessee to China.
The new WHO list makes a clearcut line-up of offending organisms; however, the list is truly a call to arms for those hoping to prevent the antibiotic apocalypse.
From pets at home to SeaWorld's main attraction, the threat of antimicrobial resistance in domesticated animals is flying under the radar amid concerns for livestock and human resistance.
As work with deadly pathogens becomes more advanced, are our biosecurity and biosafety practices regressing?
Growing issues and a controversial administration are bringing bioethics to the forefront of science and public health.
The rise of the mcr-1 gene highlights the hurdles against the bigger fight that is antimicrobial resistance
While we look to emerging infectious disease outbreaks and the threat of biological weapons, it's easy to forget the responsibilities of our domestic research.
The era of antibiotic futility is approaching, so why aren't we taking it seriously?
Is the U.S. a Pandora's box of laboratory biosafety failures?
Taking a page out of U.S. Biodefense practices may be the first step in preparing for future infectious disease outbreaks.
An unexpected patient population may play a larger role in infection control struggles
Advertisement
Advertisement
Advertisement
